Study about exhaled breath from patietns with small intestinal bacterial overgrowth

Isomoto Hajime0 个研究点目标入组 50 人开始时间: 2023年5月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)18 or above years old male or female
•(2)Patients with symptoms such as abdominal distention, abdominal pain, flatulence, burping, abdominal discomfort, chronic diarrhea/constipation lasting more than 3 months
•(3) Patients who are not infected with H. Pylori
•(4)Patients whose abdominal symptoms have not been identified by previous CT scan or upper gastrointestinal endoscopy.
•(5) Patients who are scheduled to undergo upper gastrointestinal endoscopy as a routine medical examination

•(1)Patients who have galactosemia
•(2)Patients who have taken antibiotics within 1 month
•(3)Patientswho have taken an intestinal antiflatulent, intestinal peristaltic, or PPI within 1 week
•(4)Patients requiring the use of glucagon for endoscopy
•(5)Diabetics with poorly controlled blood glucose (Hyperglycemia is expected after taking 10 g of lactulose)
•(6)Patients taking oral alpha-glucosidase inhibitors
•(7)Patients who have received other research or investigational drugs within 3 months prior to the start of treatment
•(8)Pregnant women or patients who may be pregnant
•(9)Patients who are breast-feeding
•(10)Patients with organic disease (tumor, acute ulcerative lesion, severe stenosis or obstruction, etc.)
•(11)Patients deemed inappropriate by the principal investigator and research staff

发起方

Isomoto Hajime